The survival rate is only 30% for children diagnosed with MLL-translocation leukemia. Scientists have discovered two successful therapies that slowed the progression of this leukemia in mice, which could be developed into a pediatric leukemia “super drug” to test on humans in a clinical trial.

The survival rate is only 30% for children diagnosed with MLL-translocation leukemia. Scientists have discovered two successful therapies that slowed the progression of this leukemia in mice, which could be developed into a pediatric leukemia “super drug” to test on humans in a clinical trial.: http://bit.ly/2AbTxLf Read more... http://bit.ly/2QSePrG